# Sequoia Capital China

HongShan Capital Group, formerly Sequoia Capital China, is a global venture capital and private equity firm founded in 2005. It manages around $56 billion in assets and invests across technology, healthcare, and consumer sectors.

HongShan Capital Group (HSG; Chinese: 红杉中国; pinyin: Hóngshān Zhōngguó) is a global venture capital and private equity firm founded in 2005. It was previously the China investment arm of Sequoia Capital and was known as Sequoia Capital China before being rebranded and spun off as a separate entity. The firm manages approximately $56 billion in assets and has offices in Hong Kong, Beijing, Shanghai, London, Singapore, Shenzhen, and Tokyo.

HongShan has expanded its focus over the years beyond early-stage investing to also cover growth stage, infrastructure, healthcare and consumer, and buyout funds. The firm has built a notable investment record in Chinese technology companies and has increasingly looked toward international markets for opportunities.

## Background

### Sequoia Capital China (2005 to 2023)

In 2005, Neil Shen and Zhang Fan co-founded Sequoia Capital China with the guidance of Sequoia partners Michael Moritz and Douglas Leone. The two were selected by Sequoia to lead the firm's venture in China. In 2009, Zhang resigned from Sequoia China for personal reasons, leaving Shen to be entirely in charge of Sequoia China's operations. By that period, the firm had raised a combined $1 billion for three U.S. dollar-denominated China funds and 1 billion yuan for a local currency yuan-denominated investment fund.

Afterwards, Sequoia China raised more money, mostly from US institutional investors, and built a successful investment record which included companies such as Alibaba Group, JD.com, Meituan, Pinduoduo, Shein, and ByteDance. Historically, 90% of returns came from consumer, consumer tech, and healthcare fields. No other US investment manager had the same level of success in China as Sequoia China. By 2023, Sequoia China had invested in over 1,000 projects.

In 2021, the firm acquired a controlling stake in the French fashion brand Ami Paris. In June 2023, Sequoia announced that it would be splitting off Sequoia China as a separate entity, with the process completed by 31 March 2024. This came at a time of rising tensions in China–United States relations, where Chinese leaders did not want to see US investors reaping rewards from their companies and US leaders did not want to see money being used to invest in Chinese technology such as semiconductors. However, Sequoia denied that rising tensions were the reasons for the split. Sequoia China would be rebranded as HongShan (a pinyin romanisation of its Chinese name, which means redwood) in English, but its Chinese name remained the same. Going forward, the firm would be raising capital as a Chinese venture capital firm rather than as the Chinese arm of an American venture capital firm.

### HongShan (2023 to present)

In July 2023, HongShan announced that it had set up an office in Singapore and was making plans to use it as a base to invest in Southeast Asia. It was speculated that it would be competing with Peak XV Partners, the Indian and Southeast Asian investment arm of Sequoia China that was also split off in June 2023. HongShan has stated there are no plans to open an office in the US.

In October 2023, the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party asked Sequoia in a letter to provide details about investments in [artificial intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) and other high-tech sectors made by it and HongShan. Members also questioned Sequoia if its decision to split off HongShan would insulate some capital flows from US regulatory scrutiny. This was because HongShan relied on limited partners to finance deals, so the split would not stop US institutional investors from continuing to invest in it. In addition, members also stated HongShan would be likely to scrap the national security screening mechanism that Sequoia had created to evaluate investments by its companies. Members also accused HongShan of funnelling US capital into investments that contributed to human rights abuses and military modernisation, with examples being DeepGlint and ByteDance. Additional requests included identifying any limited partners domiciled in China or that manage funds for state-owned or affiliated entities and confirming the number of HongShan's limited partners that are US investors. So far, US limited partners were not targeted, and institutional investors that invest in HongShan are confident they can continue their relationship with HongShan after the United States Department of the Treasury finalises restrictions on outbound investment mandated by an executive order.

In November 2023, it was reported that despite scrutiny from US lawmakers, several new investors signed on with HongShan. They include CalPERS and University of Washington Investment Management. Existing investors such as CPP Investment Board and Regents of the University of California added additional commitments.

In July 2024, HongShan raised its first new fund as a separate entity. It raised 18 billion RMB ($2.5 billion) for its new fund to invest in startups. In October 2024, HongShan set up a London office to look for investment opportunities in Europe with plans to make overseas investments. In November 2024, it was reported HongShan was struggling to deploy its large cash pile in a sluggish domestic market and tightening US controls.

In 2025, HSG acquired a majority stake in the audio equipment maker Marshall Group. The deal, valued at $1.1 billion, became HSG's largest investment in Europe. HSG opened an office in Tokyo, Japan in February 2025. In September 2025, HSG was shortlisted together with EQT, The Carlyle Group, and Boyu Capital to bid for a controlling stake in Starbucks' China operations. In October 2025, Bayer AG was reported to be selling its global Avelox antibiotics business to HSG. In December 2025, HSG acquired a majority stake in Italian luxury fashion company Golden Goose.

In August 2026, Bloomberg reported that HSG had held preliminary talks with investors to raise at least $1.2 billion for an early-stage fund targeting [artificial intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence), healthcare, and consumer companies. The fund would be the firm's first dollar-denominated vehicle since its separation from Sequoia Capital.

## Investment Strategy

HongShan's investment approach has evolved from its early focus on early-stage ventures to a broader strategy encompassing multiple stages and sectors. The firm has historically generated strong returns from consumer, consumer tech, and healthcare investments, which accounted for 90% of its returns. In recent years, it has expanded into infrastructure and buyout funds, allowing it to participate in larger transactions such as the Marshall Group acquisition and the potential Starbucks China bid.

The firm's international expansion reflects a strategic shift toward global opportunities. With offices in London, Singapore, and Tokyo, HongShan has positioned itself to identify investment prospects across Europe, Southeast Asia, and Japan. This diversification comes as the firm navigates challenges in the domestic Chinese market, including a sluggish economy and tightening US regulatory controls on outbound investment.

## Regulatory Scrutiny and Geopolitical Context

The split from Sequoia Capital occurred against a backdrop of heightened geopolitical tensions between the US and China. US lawmakers have expressed concerns about the flow of American capital into Chinese technology companies, particularly in sensitive areas such as [artificial intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) and semiconductors. The House Select Committee's October 2023 letter highlighted these concerns, asking for detailed information about HongShan's investments and its limited partner base.

Despite this scrutiny, HongShan has continued to attract US institutional investors, including CalPERS and the University of Washington Investment Management. The firm's ability to maintain these relationships suggests that investors see value in its investment record and are willing to navigate the regulatory environment. However, the ultimate impact of US Treasury restrictions on outbound investment remains uncertain, and HongShan's future fundraising efforts may be affected by these evolving rules.

## Notable Investments and Acquisitions

HongShan's portfolio includes some of the most prominent Chinese technology companies, such as Alibaba Group, JD.com, Meituan, Pinduoduo, Shein, and ByteDance. These investments have contributed significantly to the firm's reputation and financial performance. In the [artificial intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) sector, HongShan has been active, with investments in companies like SenseTime, reflecting a broader interest in [machine learning](https://www.wikiprompt.org/wiki/machine-learning) and [deep learning](https://www.wikiprompt.org/wiki/deep-learning) technologies.

Beyond technology, the firm has made strategic acquisitions in consumer brands, including Ami Paris, Marshall Group, and Golden Goose. These moves demonstrate HongShan's willingness to invest across sectors and geographies, leveraging its capital base to acquire established brands with global appeal. The potential acquisition of Starbucks' China operations would represent a significant expansion into the food and beverage sector, further diversifying the firm's portfolio.

## Future Outlook

As HongShan continues to operate as an independent entity, its future trajectory will depend on several factors. The firm's ability to raise new funds, particularly dollar-denominated vehicles, will be crucial for its international expansion plans. The reported $1.2 billion early-stage fund targeting [artificial intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence), healthcare, and consumer companies signals a continued focus on high-growth sectors.

The geopolitical environment remains a key uncertainty. While HongShan has stated it has no plans to open a US office, its reliance on US institutional investors creates ongoing exposure to regulatory changes. The firm's success in navigating these challenges while maintaining its investment performance will determine its long-term position in the global venture capital landscape.

---
Source: https://www.wikiprompt.org/wiki/sequoia-capital-china
License: CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/)
Last updated: 2026-09-08T15:33:12.643+00:00